1330 related articles for article (PubMed ID: 17724226)
1. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
2. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
[TBL] [Abstract][Full Text] [Related]
4. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.
Nagai N; Oike Y; Noda K; Urano T; Kubota Y; Ozawa Y; Shinoda H; Koto T; Shinoda K; Inoue M; Tsubota K; Yamashiro K; Suda T; Ishida S
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2925-31. PubMed ID: 16043867
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells.
Liu HQ; Wei XB; Sun R; Cai YW; Lou HY; Wang JW; Chen AF; Zhang XM
Life Sci; 2006 Feb; 78(12):1293-8. PubMed ID: 16343550
[TBL] [Abstract][Full Text] [Related]
6. Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.
Wakamatsu K; Nanki T; Miyasaka N; Umezawa K; Kubota T
Arthritis Res Ther; 2005; 7(6):R1348-59. PubMed ID: 16277688
[TBL] [Abstract][Full Text] [Related]
7. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
Chan YC; Leung PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):10-8. PubMed ID: 17616560
[TBL] [Abstract][Full Text] [Related]
9. Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation.
Kubota S; Ozawa Y; Kurihara T; Sasaki M; Yuki K; Miyake S; Noda K; Ishida S; Tsubota K
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9142-8. PubMed ID: 22058332
[TBL] [Abstract][Full Text] [Related]
10. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
13. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
[TBL] [Abstract][Full Text] [Related]
14. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes.
Cardile V; Libra M; Caggia S; Frasca G; Umezawa K; Stivala F; Mazzarino MC; Bevelacqua Y; Coco M; Malaponte G
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):679-83. PubMed ID: 20337659
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
[TBL] [Abstract][Full Text] [Related]
16. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation.
Kubota S; Kurihara T; Mochimaru H; Satofuka S; Noda K; Ozawa Y; Oike Y; Ishida S; Tsubota K
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3512-9. PubMed ID: 19279313
[TBL] [Abstract][Full Text] [Related]
17. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
18. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
[TBL] [Abstract][Full Text] [Related]
19. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]